US › Healthcare

Wave Life Sciences Ltd (WVE)

US · Healthcare · Biotechnology

$6.00+4.53%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$2.3M
Revenue YoY
-73.9%
Net profit
$-69.4M
Profit YoY
-37.4%
EPS
$-0.34
EPS estimate
$-0.31
Net margin
-3,052.6%

EPS came in at -0.34 against a street estimate of -0.31 — a miss of 9.7%.

Key statistics

Market cap
$1.13B
Forward P/E
0.0
P/B
2.40
Book value
$2.76
EPS (TTM)
$-1.08
52-week high
$21.73
52-week low
$5.02
50-day MA
$5.98
200-day MA
$9.60
Beta
-1.29

Analyst view

Analysts rate Wave Life Sciences Ltd a strong buy (12 buy, 1 hold, 0 sell out of 13) with an average price target of $19.62.

Shareholding

Insiders
15.51%
Institutions
80.80%

Largest institutional holders

FundStake
RA Capital Management, LLC13.69%
GSK PLC9.26%
BlackRock Inc7.16%
Maverick Capital Ltd5.16%
T. Rowe Price Associates, Inc.4.42%
Driehaus Capital Management LLC2.76%
Federated Hermes Inc2.70%
FMR Inc2.64%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Wave Life Sciences Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.